Skip to main content

IDENTIFICACION DE NUEVAS DIANAS MOLECULARES IMPLICADAS EN EL DESARROLLO DEL REMODELADO ADVERSO CARDIACO Y APLICACION TERAPEUTICA DE NANOPARTICULAS ANTI-FIBROTICAS

PI19/00501

•
Funding agency name Instituto de Salud Carlos III
Funding agency acronym ISCIII
Program Programa Estatal de Generación de Conocimiento y Fortalecimiento del Sistema Español de I+D+I
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de Investigación en Salud
Call year 2019
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre FUNDACION INSTITUTO DE INVESTIGACION SANITARIA DE NAVARRA
Execution centre INSTITUTO DE INVESTIGACION SANITARIA DE NAVARRA (IdISNA)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publication Artículo científico (JournalArticle)

Delivery of cardiovascular progenitors with biomimetic microcarriers reduces adverse ventricular remodeling in a rat model of chronic myocardial infarction

  • Garbayo, Elisa
  • Ruiz-Villalba, Adrián
  • Hernández, Silvia C.
  • Saludas, Laura
  • Abizanda, Gloria
  • Pelacho, Beatriz
  • Roncal Mancho, Carmen
  • Sánchez, B. (Belén)
  • Palacios, Itziar
  • Prósper, Felipe
  • Blanco-Prieto, María J.
Despite tremendous progress in cell-based therapies for heart repair, many challenges still exist. To enhance the therapeutic potential of cell therapy one approach is the combination of cells with biomaterial delivery vehicles. Here, we developed a biomimetic and biodegradable micro-platform based on polymeric microparticles (MPs) capable of maximizing the therapeutic potential of cardiac progenitor cells (CPCs) and explored its efficacy in a rat model of chronic myocardial infarction. The transplantation of CPCs adhered to MPs within the infarcted myocardial microenvironment improved the long-term engraftment of transplanted cells for up to one month. Furthermore, the enhancement of cardiac cellular retention correlated with an increase in functional recovery. In consonance, better tissue remodeling and vasculogenesis were observed in the animals treated with cells attached to MPs, which presented smaller infarct size, thicker right ventricular free wall, fewer deposition of periostin and greater density of vessels than animals treated with CPCs alone. Finally, we were able to show that part of this beneficial effect was mediated by CPC-derived extracellular vesicles (EVs). Taken together, these findings indicate that the biomimetic microcarriers support stem cell survival and increase cardiac function in chronic myocardial infarction through modulation of cardiac remodeling, vasculogenesis and CPCs-EVs mediated therapeutic effects. The biomimetic microcarriers provide a solution for biomaterial-assisted CPC delivery to the heart., This work was supported by the FEDER/Ministry of Science and Innovation-State Research Agency/SAF2017-83734-R and funds from the ISCIII and co-financed by FEDER (PI19/00501), Red TERCEL RETIC RD16/0011/0005 and MINECO (Program RETOS Cardiomesh RTC-2016-4911-1), ERANET II (Nanoreheart AC15/00050), and EU's H2020 Programme for research, technological development and demonstration under grant agreement BRAV¿-874827. Elisa Garbayo is supported by a FSE/Ministry of Science and Innovation-State Research Agency RYC2018-025897-I. Adrian Ruiz-Villalba is supported by the Spanish Ministry of Sciences and Innovations FSE/MINECO-AEI(IJCI-2016-30254), and the Spanish Ministerio de Ciencia, Innovación y Universidades (grant RTI2018-095410-BI00). We thank Filippo Roli and Elena Iglesias for technical support.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

A Multimodal Scaffold for SDF1 Delivery Improves Cardiac Function in a Rat Subacute Myocardial Infarct Model

  • Perez-Estenaga, Iñigo
  • Chevalier, Merari Tumin
  • Peña, Estefania
  • Abizanda, Gloria
  • Alsharabasy, Amir M.
  • Larequi, Eduardo
  • Cilla, Myriam
  • Perez, Marta M.
  • Gurtubay, Jon
  • Garcia-Yebenes Castro, Manuel
  • Prosper, Felipe
  • Pandit, Abhay
  • Pelacho, Beatriz
Ischemic heart disease is one of the leading causes of death worldwide. The efficient delivery of therapeutic growth factors could counteract the adverse prognosis of post-myocardial infarction (post-MI). In this study, a collagen hydrogel that is able to load and appropriately deliver pro-angiogenic stromal cell-derived factor 1 (SDF1) was physically coupled with a compact collagen membrane in order to provide the suture strength required for surgical implantation. This bilayer collagen-on-collagen scaffold (bCS) showed the suitable physicochemical properties that are needed for efficient implantation, and the scaffold was able to deliver therapeutic growth factors after MI. In vitro collagen matrix biodegradation led to a sustained SDF1 release and a lack of cytotoxicity in the relevant cell cultures. In vivo intervention in a rat subacute MI model resulted in the full integration of the scaffold into the heart after implantation and biocompatibility with the tissue, with a prevalence of anti-inflammatory and pro-angiogenic macrophages, as well as evidence of revascularization and improved cardiac function after 60 days. Moreover, the beneficial effect of the released SDF1 on heart remodeling was confirmed by a significant reduction in cardiac tissue stiffness. Our findings demonstrate that this multimodal scaffold is a desirable matrix that can be used as a drug delivery system and a scaffolding material to promote functional recovery after MI.